Business Description
Hofseth BioCare ASA
ISIN : NO0010598683
Total Employee Number:
84Compare
Compare
Traded in other countries / regions
HBC.NorwayHBCO.Sweden0Q6H.UKHBQ.GermanyHOFBF.USA IPO Date
2019-02-18Description
Hofseth BioCare ASA is a Norway-based company engaged in the business of developing, manufacturing, marketing, and selling marine ingredients such as oil, calcium, and protein products. Its brands, which also generate revenue, include salmon oil (OmeGo), water-soluble protein (ProGo), calcium/collagen (CalGo and NT-II), and non-soluble protein (PetGo), all of which are produced in the Midsund plant. The firm sells its products to various segments of the human nutrition market, such as sports nutrition, supplements, and health foods, as well as to the market within nutrition for the pet and feed industry. Geographically, the company generates maximum revenue from Europe, followed by North America and Asia.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | -0.3 | |||||
Debt-to-Equity | -3.19 | |||||
Debt-to-EBITDA | -4.91 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 0.1 | |||||
Beneish M-Score | -3.75 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 24.8 | |||||
3-Year EBITDA Growth Rate | 12.1 | |||||
3-Year EPS without NRI Growth Rate | 3.7 | |||||
3-Year FCF Growth Rate | 11.4 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 52.28 | |||||
9-Day RSI | 52.77 | |||||
14-Day RSI | 53.14 | |||||
3-1 Month Momentum % | -8.99 | |||||
6-1 Month Momentum % | -5.59 | |||||
12-1 Month Momentum % | -47.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.52 | |||||
Quick Ratio | 0.29 | |||||
Cash Ratio | 0.19 | |||||
Days Inventory | 150.92 | |||||
Days Sales Outstanding | 34.2 | |||||
Days Payable | 251.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -18.75 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 37.62 | |||||
Operating Margin % | -47.55 | |||||
Net Margin % | -56.47 | |||||
EBITDA Margin % | -29.36 | |||||
FCF Margin % | -21.1 | |||||
OCF Margin % | -6.63 | |||||
ROA % | -35.94 | |||||
ROIC % | -34.78 | |||||
3-Year ROIIC % | 14.17 | |||||
ROC (Joel Greenblatt) % | -82.35 | |||||
ROCE % | -67.55 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2.46 | |||||
EV-to-EBIT | -8.76 | |||||
EV-to-EBITDA | -13.67 | |||||
EV-to-Revenue | 4.01 | |||||
EV-to-FCF | -19.45 | |||||
Price-to-GF-Value | 0.62 | |||||
Price-to-Median-PS-Value | 0.31 | |||||
Earnings Yield (Greenblatt) % | -11.42 | |||||
FCF Yield % | -7.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hofseth BioCare ASA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 21.133 | ||
| EPS (TTM) (€) | -0.029 | ||
| Beta | 1.6353 | ||
| 3-Year Sharpe Ratio | 0.11 | ||
| 3-Year Sortino Ratio | 0.23 | ||
| Volatility % | 57.11 | ||
| 14-Day RSI | 53.14 | ||
| 14-Day ATR (€) | 0.02332 | ||
| 20-Day SMA (€) | 0.1029 | ||
| 12-1 Month Momentum % | -47.74 | ||
| 52-Week Range (€) | 0.0772 - 0.154 | ||
| Shares Outstanding (Mil) | 473.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hofseth BioCare ASA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hofseth BioCare ASA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-06 | In 109 days | ||
| Second quarter earnings results for 2026 | 2026-08-21 | In 32 days | ||
| General meeting for 2026 | 2026-06-30 11:00 | 0.10 (+2.15%) | ||
| First quarter earnings results for 2026 | 2026-05-08 | 0.09 (-12.04%) | ||
| Annual report for 2025 | 2026-03-27 | 0.11 (+0.46%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-13 | 0.10 (+0.21%) | ||
| Third quarter earnings results for 2025 | 2025-11-07 | 0.14 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-22 | 0.14 (-0.70%) | ||
| General meeting for 2025 | 2025-05-23 13:00 | 0.17 (-1.44%) | ||
| First quarter earnings results for 2025 | 2025-05-16 | 0.19 (+4.05%) |
Show
Entries
Hofseth BioCare ASA Frequently Asked Questions
What is Hofseth BioCare ASA(STU:HBQ)'s stock price today?
The current price of STU:HBQ is €0.11. The 52 week high of STU:HBQ is €0.15 and 52 week low is €0.08.
When is next earnings date of Hofseth BioCare ASA(STU:HBQ)?
The next earnings date of Hofseth BioCare ASA(STU:HBQ) is 2026-08-21.
Does Hofseth BioCare ASA(STU:HBQ) pay dividends? If so, how much?
Hofseth BioCare ASA(STU:HBQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Hofseth BioCare ASA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers